<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="of illness.10 CP was also used in the West African" exact="Ebola" post="epidemic in 2013. Eightyâ€�four patients received 500â€‰mL of CP."/>
 <result pre="of action of CP in other viral infections such as" exact="Ebola" post="virus and Respiratory Syncytial Virus is mainly viral neutralization."/>
 <result pre="EdwardsT, de LamballerieX, et al. Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in Guinea. N Engl J Med. 2016;374:33â€�42.26735992"/>
 <result pre="role for fc function in therapeutic monoclonal antibodyâ€�mediated protection against" exact="Ebola" post="virus. Cell Host Microbe. 2018;24:221â€�233.30092199 20OzmaMA, MaroufiP, KhodadadiE, et"/>
 <result pre="et al. Antibody responses to SARSâ€�CoVâ€�2 in patients of novel" exact="coronavirus disease 2019." post="Clin Infect Dis. 202010.1093/cid/ciaa344. 27CasadevallA, ScharffMD. Return to the"/>
 <result pre="10.3201/eid2607.200839.32243255 39KatzelnickLC, GreshL, HalloranME, et al. Antibodyâ€�dependent enhancement of severe" exact="dengue disease" post="in humans. Science. 2017;358:929â€�932.29097492 40TetroJA. Is COVIDâ€�19 receiving ADE"/>
</results>
